课题基金 / 基金详情

Development of tools for site-directed analysis of gene function

Development of tools for site-directed analysis of gene function
基因功能定点分析工具的开发
批准号:
10185650
负责人:
KARL J CLARK
金额:
$3.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-01 至 2024-02-29

项目摘要

项目成果

KARL J CLARK的其他基金

相似基金

相关文献

中文摘要
翻译
组蛋白伴侣Rbbp4是多种染色质重塑复合物的组成部分
英文摘要
The histone chaperone Rbbp4 is a component of multiple chromatin remodeling complexes involved in cellular identity, plasticity, and reprogramming (Cheloufi and Hochedlinger, 2017; Clemot et al., 2018; Conway et al., 2015). Rbbp4 also plays a significant role in cell cycle control as a component of the MuvB complex that regulates cell cycle gene expression. Together with transcription factors B-Myb and FoxM1, the MuvB complex controls the timing of gene expression in G1/S (growth and DNA synthesis) and G2/M (mitosis) that allows progression through the cell cycle (Fischer and Muller, 2017). We previously demonstrated in a zebrafish model of rb1 defective embryonal brain tumors that rbbp4 is elevated more than 10-fold, and we showed that in rbbp4 mutant embryos neural progenitors undergo tp53-dependent apoptosis (Schultz et al., 2018). These results indicate inhibition of Rbbp4 may block the proliferation and survival of brain cancer cells by activating cell cycle arrest through the Tp53 programmed cell death pathway (Engeland, 2018). However, while most malignant human brain cancers show elevated Rbbp4 expression (Schultz, Kool, McGrail unpublished results), many also harbor inactivating mutations in Tp53. A deeper understanding of the mechanism by which Rbbp4 contributes to neural progenitor cell cycle progression may lead to new targets, that in combination with Rbbp4 inhibitors, lead to brain tumor cell death. To address this, we propose to apply our innovative CRISPR/Cas9 targeted integration strategy to generate novel proneural cell cycle reporter and foxm1 conditional gene inactivation zebrafish lines. These will allow us to examine how Rbbp4 and FoxM1 cooperate specifically in neural progenitor cell cycle progression during brain development. The results will yield new insight into neural progenitor cell cycle control and how its dysregulation drives unregulated proliferation of brain tumor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of tools for site-directed analysis of gene function
  • 批准号:
    10187374
  • 项目类别:
  • 资助金额:
    $6.23万
  • 财政年份:
    2020
  • 负责人:
    KARL J CLARK
  • 依托单位:
Development and genetics of rapid neuroendocrine stress response
  • 批准号:
    9796476
  • 项目类别:
  • 资助金额:
    $34.19万
  • 财政年份:
    2019
  • 负责人:
    KARL J CLARK
  • 依托单位:
Development and genetics of rapid neuroendocrine stress response
  • 批准号:
    10397544
  • 项目类别:
  • 资助金额:
    $34.19万
  • 财政年份:
    2019
  • 负责人:
    KARL J CLARK
  • 依托单位:
Development and genetics of rapid neuroendocrine stress response
  • 批准号:
    10292709
  • 项目类别:
  • 资助金额:
    $1.43万
  • 财政年份:
    2019
  • 负责人:
    KARL J CLARK
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: